Sorted By:

Relevance


Examining the brain in The New Era of Medicine

PhRMA  |  Blog Post

Eric Siemers, senior medical director, Alzheimer's Global Development Team at Eli Lilly and Co., who currently directs late stage clinical research efforts concerning investigational treatments for Alzheimer’s disease, will speak on a panel that examines the current state of treatments to combat neurological disorders.
http://catalyst.phrma.org/examining-the-brain-in-the-new-era-of-medicine

Director – Public Affairs

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org/careers/director-public-affairs

What they are saying: Study on cancer R&D costs is not an accurate representation of marketplace

PhRMA  |  Blog Post

Leonard Lichtenfeld, M.D., deputy chief medical officer, American Cancer Society “As far as I’m concerned, this paper sets a lower bound, and that’s all.” – Derek Lowe, Ph.D., Science Translational Medicine  
http://catalyst.phrma.org/what-they-are-saying-study-on-cancer-rd-costs-is-not-an-accurate-representation-of-marketplace

Quantifying Improvements in Life Quality of Individuals with Complex Chronic Medical Conditions Over the Past Decade

PhRMA  |  Report

In particular, this paper highlights a few select medical conditions that have seen tremendous progress over the past decade in improving both life expectancy and quality of life for patients.
https://www.phrma.org/report/quantifying-improvements-in-life-quality-of-individuals-with-complex-chronic-medical-conditions-over-the-past-decade

Medicare Monday: PhRMA's comments on new direction for CMMI

PhRMA  |  Blog Post

Read our full comments here, and learn more at PhRMA.org/CMMI.
http://catalyst.phrma.org/medicare-monday-phrmas-comments-on-new-direction-for-cmmi

Aspen Spotlight Health 360° VIDEO PREMIERE:
New Virtual Reality Video Takes You Inside The Lab with Researchers to Showcase Amazing Advancements in Medicine

PhRMA  |  Press Release

Ubl, President & CEO of PhRMA, will participate in a panel discussion Friday morning June 23rd examining the value medicines bring patients and how payment and delivery systems can meet 21st century demands. 
https://www.phrma.org

A critical opportunity to prevent prescription drug abuse

PhRMA  |  Blog Post

We are committed to working with the administration’s newly established Opioid Policy Steering Committee and other stakeholders to find solutions to address this current public health crisis.  
http://catalyst.phrma.org/a-critical-opportunity-to-prevent-prescription-drug-abuse

New First-of-Its-Kind Study Shows Growing Share of Medicine List Prices Going to Rebates and Supply Chain

PhRMA  |  Press Release

Last year, PhRMA outlined a series of policy proposals to improve the competitive market and enable the private sector to lead the move to a more value-driven health care system.
https://www.phrma.org/press-release/new-first-of-its-kind-study-shows-growing-share-of-medicine-list-prices-going-to-rebates-and-supply-chain

Senior Director – Science and Regulatory Advocacy (Drug Development Tools)

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org

How much are hospitals marking up the price of medicines? The answer may surprise you.

PhRMA  |  Blog Post

While hospital markups lead to higher costs for patients, employers and payers, these markups are often overlooked in conversations about medicine costs.
http://catalyst.phrma.org/how-much-are-hospitals-marking-up-the-price-of-medicines-the-answer-may-surprise-you

Radio Ad: Middlemen

PhRMA  |  From PhRMA

.soundcloud.com/player/?
https://www.phrma.org/media/radio-ad-middlemen

Medicare Monday: Call for repeal of IPAB intensifies

PhRMA  |  Blog Post

In a letter to Congress, 16 organizations called for the repeal of IPAB as soon as possible: “Too much power is being vested into an unelected board, or one person, the secretary of Health and Human Services, if the board has taken no action to prepare a proposal to cut spending.
http://catalyst.phrma.org/medicare-monday-call-for-repeal-of-ipab-intensifies

Senior Manager – Advocacy and Strategic Alliances

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org

PhRMA Board of Directors Elects New Officers, Welcomes New Member Company

PhRMA  |  Press Release

“We are seeing the power of innovation in every aspect of today’s approaches to medical discovery and are eager to demonstrate how bold advancements in innovation can address the costs of disease.”
https://www.phrma.org/press-release/phrma-board-of-directors-elects-new-officers-welcomes-new-member-company

The Value Collaborative

PhRMA  |  From PhRMA

Regulatory and Legal Barriers That Limit Value-Based Payment Arrangements Must Be Addressed Private payers and biopharmaceutical manufacturers have made clear their interest in pursuing innovative contracting approaches to more directly link prescription medicine pricing to value.
https://www.phrma.org/advocacy/the-value-collaborative

New report and event examine the new era of vaccines

PhRMA  |  Blog Post

Speakers from GSK, Merck and Pfizer will all appear on stage.
http://catalyst.phrma.org/new-report-and-event-examine-the-new-era-of-vaccines

Senior Director – Advocacy and Strategic Alliances

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org/careers/senior-director-advocacy-and-strategic-alliances

Amgen Chairman and CEO Robert A. Bradway Elected PhRMA Board Chairman-Elect

PhRMA  |  Press Release

Prior to joining Bayer Healthcare, Brandicourt worked at Pfizer for 13 years, where he served as a member of the executive leadership team and as president and general manager of the emerging markets and established products business units.
https://www.phrma.org

Manager – Advocacy and Strategic Alliances (State)

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.
https://www.phrma.org

Prescription Drug Misuse, Abuse & Disposal

PhRMA  |  From PhRMA

The National Governor’s Association Prescription Drug Abuse Reduction Policy Academy, a year-long exercise in strategic planning aimed at reducing prescription drug abuse.
https://www.phrma.org/advocacy/safety/prescription-misuse-abuse

PhRMA Foundation recognizes inaugural Challenge Award recipients

PhRMA  |  Blog Post

The authors of this paper propose that the implementation of generic and disease/condition specific PROMs across health care systems will advance a value-driven health care system.
http://catalyst.phrma.org/phrma-foundation-recognizes-inaugural-challenge-award-recipients

ICYMI: New report outlines steps for greater transparency in health care

PhRMA  |  Blog Post

This includes a public awareness campaign, better marketing of the tools available to consumers and policy recommendations for lawmakers.
http://catalyst.phrma.org/icymi-new-report-outlines-steps-for-greater-transparency-in-health-care

Our Commitment to Turning the Tide Against Cancer

PhRMA  |  Blog Post

  To view the paper and other Turning the Tide Against Cancer resources, please click here.
http://catalyst.phrma.org/our-commitment-to-turning-the-tide-against-cancer

Roy Herbst

PhRMA  |  Biography

He has authored more than 200 peer-reviewed papers and has current grant funding for his work from numerous sources including the National Cancer Institute, AACR and multiple charitable foundations.
https://www.phrma.org/biography/roy-herbst

Improve Access to Out of Pocket Cost Information

PhRMA  |  Video

One policy solution for delivering innovative treatments to patients is to engage and empower consumers by making more information about health care out-of-pocket costs available.
https://www.phrma.org/video/improve-access-to-out-of-pocket-cost-information

You have reviewed the first 175 results out of 1101. Each page contains 25 results. You're on page 7.

prev 7 8 9 10 11 12 next